(1) Represents costs incurred to better align capacity to preclinical market demand and reduce overall cost structure. (2) Consists of gain on sale of investments $16,400 and asset impairment charges ...
Discover the crucial differences between pro forma and GAAP financial statements. Learn why companies use both and the ...
"Late-Stage Development first quarter revenues grew 16.8% year-on-year to $373 million. Central laboratories and clinical development grew 20% and 18%, respectively, which more than offset a decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback